Printer Friendly
The Free Library
4,491,428 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biovail to Present at the Scotia Capital Pharmaceutical & Biotechnology Conference.


TORONTO -- Biovail Corporation (NYSE:BVF BVF - Bearing Versus Frequency
BVF - Berufsverband der Frauenärzte eV (Muenchen, Germany)
BVF - Biovail Corporation (stock symbol)
)(TSX:BVF) today announced that the Company will present at the Scotia Capital Pharmaceutical & Biotechnology Conference at the Le Royal Meridien King Edward Hotel in Toronto.

Biovail's presentation is scheduled for Wednesday, April 26, 2006, at 10 a.m. EDT. A live and archived Web cast will be available on the Investor Relations page of Biovail's Web site at www.biovail.com.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company, engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products utilizing advanced drug-delivery technologies. For more information about Biovail, visit the company's Web site at www.biovail.com.

For further information, please contact Ken Howling at 905-286-3000 or send inquiries to ir@biovail.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:Apr 21, 2006
Words:124
Previous Article:AUDIO from Medialink: What's the Scoop?
Next Article:Danville Based Diablo Valley Bank Reports Record First Quarter Earnings and Total Assets of $214 Million.
Topics:



Related Articles
Biovail Announces Offering of US$275 Million Senior Subordinated Notes Due 2010.
Biovail Prices US$400 Million 7.875% Senior Subordinated Notes Due 2010.
Biovail to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference.
Biovail to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference.
Biovail to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference.
Biovail to Present at the UBS Global Specialty Pharmaceuticals Conference.
Biovail to Present at the Deutsche Bank Annual Health Care Conference.
Biovail to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference.
Biovail to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference.
Biovail to Present at the Scotia Capital Spring Growth Conference.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles